Retro-inverso analog of the (5-14) decapeptide of equine angiote

Chemistry of carbon compounds – Miscellaneous organic carbon compounds – C-metal

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07C10352

Patent

active

045605050

ABSTRACT:
There is provided an analog of the (5-14) decapeptide of equine angiotensinogen which is partially inverted at the Phe-Val bond, and which has the formula ##STR1## This retro-inverso analog inhibits renin with high resistance to enzymatic degradation and it can be used in the treatment of renin-dependent hypertension.

REFERENCES:
patent: 4424207 (1984-01-01), Szelke et al.
patent: 4439360 (1984-03-01), Verdini et al.
Pallai et al., American Peptide Symposium, (7th: 1981: U. of Wisconsin), "Configuration of Substituted Malonyl and Gem-Diamino Derivatives of Peptides", pp. 85-88.
Burton et al., Medical Sciences, vol. 77, No. 9, 5476-5479, (1980).
Cody et al., Biochemical and Biophysical Research Communications, vol. 97, No. 1, 230-235, (1980).
Radhakrishna et al., J. Org. Chem., vol. 44, No. 10, 1746-1747, (1979).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Retro-inverso analog of the (5-14) decapeptide of equine angiote does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Retro-inverso analog of the (5-14) decapeptide of equine angiote, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Retro-inverso analog of the (5-14) decapeptide of equine angiote will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1478074

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.